UN REPORTS PROGRESS IN GAZA POLIO VACCINATION CAMPAIGN
The United Nations reported progress in Gaza’s polio vaccination campaign, despite challenging conditions. The first phase of the campaign, aimed at vaccinating 640,000 children under 10, is expected to conclude on Thursday. By Wednesday, nearly 530,000 children had received their initial vaccine dose. A successful campaign will require a follow-up booster round in a few weeks. The campaign faced difficulties, including a brief halt when Israeli troops detained a UN convoy. Despite this, organizers have reported no major issues since. The campaign is crucial as traces of poliovirus were detected in Gaza’s wastewater, and a recent case marked the first polio occurrence in 25 years. The outbreak poses a risk to neighboring regions. Humanitarian pauses in fighting have been arranged to facilitate the vaccination process, and Israel has begun offering booster vaccines to its soldiers. (New York Times)
DARZI REPORT HIGHLIGHTS NHS FUNDING ISSUES AND STRAIN
Lord Ara Darzi’s recent report on the NHS highlights severe issues, including inadequate funding leading to deteriorating facilities, such as overcrowded mental health wards and outdated buildings. The A&E services are critically strained, resulting in preventable deaths due to delays. Despite these grim findings, Darzi offers hope, noting the NHS’s “extraordinary depth of clinical talent” and its increased resources. He acknowledges the need for substantial capital investment to modernize infrastructure and improve conditions. Darzi’s report, which will inform a 10-year NHS plan by Labour, emphasizes re-engaging staff to address declining productivity and suggests shifting care to community settings, which will require additional funding. The challenge remains significant, with the new government facing the financial and operational complexities left by its predecessors, making the NHS a central and costly issue to address. (The Guardian)
VEUPATHDB SHUTDOWN SPARKS CONCERN AMONG RESEARCHERS
The shutdown of VEuPathDB, a vital resource for parasitology and vector biology supported by NIAID for 20 years, has sparked widespread concern. The database, which provides crucial data on parasites causing diseases like malaria and Chagas, will go offline this weekend. Although NIAID plans to replace it with new platforms, including BRC-Analytics, researchers fear these won’t fully replicate VEuPathDB’s capabilities. The transition will take months, during which many researchers will lose access to essential tools and data. Critics argue that NIAID’s shift to competitive grants, despite VEuPathDB’s significant user base and impact, may disrupt critical research and delay progress in tackling neglected diseases. Calls for an extension of VEuPathDB’s availability until the new systems are fully operational highlight the urgent need for adequate planning and support for affected scientists. (Science)
SPACEX POLARIS DAWN ACHIEVES HISTORIC SPACEWALK MILESTONE
In a historic achievement, SpaceX’s Polaris Dawn mission saw the first non-government astronauts conduct a spacewalk. At 6:12 a.m. ET, the crew, including Shift4 Payments CEO Jared Isaacman and SpaceX engineers Anna Menon and Sarah Gillis, performed this milestone outside the Crew Dragon capsule. The spacecraft was depressurized, exposing the crew to the vacuum of space for about two hours. Isaacman and Gillis spent around 20 minutes outside, testing new EVA suits designed to be less restrictive than traditional ones. The spacewalk occurred at altitudes between 190 and 700 kilometers, with the capsule traveling faster than 1,400 kilometers. This mission highlights SpaceX’s progress in making space travel more accessible and efficient. (CNN)
Sign up for the Daily Dose Newsletter and get every morning’s best science news from around the web delivered straight to your inbox? It’s easy like Sunday morning.
IS SPACEX POLARIS DAWN SPACEWALK ILLEGAL?
On Thursday morning, SpaceX’s Polaris Dawn mission will make history as the first private crew to conduct a spacewalk. Launched on Tuesday, Polaris Dawn is led by billionaire Jared Isaacman and includes two SpaceX employees and a former military pilot. This five-day mission takes civilians farther from Earth than any crewed mission since Apollo 1972. Unlike NASA missions, Polaris Dawn is not government-regulated, sparking debate over its adherence to the Outer Space Treaty (OST) of 1967. The OST, signed during the Cold War, aims to keep space exploration open and beneficial for all humanity. It also requires non-governmental space activities to be authorized and continuously supervised by their home countries. However, the FAA currently does not regulate commercial human spaceflight safety, leaving SpaceX to oversee its own missions. Critics argue this might violate the OST’s supervisory requirements, while others believe the treaty’s broad language can accommodate new developments in private space exploration. (Al-Jazeera)
ISPACE GEARS UP FOR SECOND MOON LANDING MISSION
Japanese space exploration company ispace is gearing up for its second moon landing mission, scheduled to launch as early as December. The “Hakuto-R Mission 2” will be propelled by a SpaceX Falcon 9 rocket from Florida and aims for a lunar landing after a four-to-five-month journey. This mission follows ispace’s initial attempt in April 2023, which ended in failure due to an altitude miscalculation. Chief Executive Takeshi Hakamada expressed enthusiasm about the upcoming re-attempt, hoping to build on the success of U.S.-based Intuitive Machines, which achieved the world’s first private moon landing in February. Founded by Hakamada in 2010, ispace has grown to around 300 employees across Japan, the U.S., and Luxembourg. The renewed focus on lunar exploration highlights the moon’s potential for discovering vital resources, as countries like India, Japan, and China continue their lunar missions. The U.S. also plans a return to the moon with its Artemis program set for 2026. (Asahi)
ITP TO TEST VIAGRA AND CAPTOPRIL ON MICE LIFESPAN
Later this year, the Interventions Testing Program (ITP) will test sildenafil citrate (Viagra) and captopril on 240 mice each, aiming to assess their effects on lifespan. This 22-year-old National Institute on Aging project evaluates compounds to extend mouse longevity, with hopes for human applications. The ITP has tested over 60 substances, finding that some, like rapamycin, significantly extend lifespans. The program’s rigorous methods, including testing at multiple sites and using genetically diverse mice, ensure reliable results. However, translating these findings to human treatments remains challenging due to regulatory hurdles, as the FDA does not consider aging a disease. Despite this, the ITP has been influential, debunking ineffective treatments and identifying promising ones. It continues to attract numerous proposals for new compounds, highlighting its ongoing importance in aging research. (Science)
ANCIENT GENOMES REVISE RAPA NUI COLLAPSE NARRATIVE
A recent study analyzing ancient genomes from Rapa Nui (Easter Island) has challenged the narrative of a catastrophic population collapse before European contact. Previously popularized by Jared Diamond’s Collapse, the theory suggested the island’s early inhabitants devastated their environment, leading to a significant population decline. However, the new research, published on September 11 in Nature, debunks this claim. It reveals that the Rapanui population grew steadily until the 19th century and disproves the dramatic decline theory. The study also confirms that ancient Rapanui had Native American ancestry, indicating pre-colonial contact with Indigenous Americans, likely dating to the 14th century. The research, conducted with input from Rapa Nui officials and community members, underscores the importance of repatriating remains held in museums. This finding, supported by both genetic evidence and historical analysis, provides a more accurate picture of Rapa Nui’s history and its interactions with other cultures. (Nature)
Leave a Reply